Join Telegram
LIVE30 Sep 2026, 03:19 AM IST
Home / IPO / Parabolic Drugs
UPCOMINGSME

Parabolic Drugs IPO

Open — · Close — · Listing —

Price BandTBA
Live GMPNO GMP
SubscriptionPENDING
Issue Size₹200.00 Cr

Financial Performance

Parabolic Drugs IPO — dedicated financial performance page.

Financial performance

Year-wise operating scale, profitability and balance-sheet context.
Full financials ↗
Assets579.93₹ Cr · +303.7% vs prior year
Net Worth111.34₹ Cr · +241.6% vs prior year

FY09

Assets491.00
Net Worth105.66
Total Debt264.03
RevenueAnnualised basis394.37
EBITDAAnnualised basis58.76
PATAnnualised basis21.09
EBITDA Margin (%)14.90

FY08

Assets285.58
Net Worth62.31
Total Debt159.42
RevenueAnnualised basis273.29
EBITDAAnnualised basis48.54
PATAnnualised basis29.67
EBITDA Margin (%)17.76

FY07

Assets143.65
Net Worth32.59
Total Debt69.66
RevenueAnnualised basis149.34
EBITDAAnnualised basis23.01
PATAnnualised basis13.59
EBITDA Margin (%)15.41

30-Sep-09

Assets579.93
Net Worth111.34
Total Debt343.22
RevenueAnnualised basis232.35
EBITDAAnnualised basis39.17
PATAnnualised basis12.41
IPO UPDATE ALERTS

Track Parabolic Drugs without missing an update

Register for subscription, GMP, allotment and listing notifications.

Register for IPO Updates →